The final panel at this year’s Anglonordic Life Science Conference was led by Mike Ward, Global Head of Life Sciences & Healthcare Thought Leadership at Clarivate, who asked life science leaders for their wisdom on the subject: “If I knew then, what I know now.” The expert panel had a wealth of experience to draw […]
We were privileged to hear visionary insights during Mike Ward’s fascinating fireside chat with Werner Lanthaler, CEO of Evotec. In the discussion, he asked Werner to share his views about the sector and big macro issues, as well as what it takes to build a biotech. This is what we learned: The teenage Werner wanted […]
Two weeks ago, Optimum hosted its 14th Annual Healthcare Investor Conference and wow, what a fantastic event it was! After two years of disruption, we were delighted to be meeting again in person. While virtual meetings have been a fantastic boon during these difficult times, nothing can beat meeting and sharing ideas and opinions face-to-face, […]
Mike Ward, Global Head of Thought Leadership at Decision Resources Group, part of Clarivate, chaired a panel of top industry executives at the Anglonordic Life Sciences Conference: Renee Aguiar-Lucander, CEO Calliditas Therapeutics, Steven Powell, CEO eTheRNA immunotherapies and Roel Bulthuis, Managing Partner at INKEF Capital, shared key decisions that shaped the fate of their various […]
Francesco de Rubertis, a co-founder of Medicixi Ventures, has unveiled the next generation of the venture-backed asset-centric biopharma model with the creation of Centessa Pharmaceuticals Ltd. The new company was created by acquiring, in all-share transactions, total control of 10 companies from the Medicxi portfolio. Read more at BioWorld.com
